Cytoreductive Nephrectomy May Up Survival in Papillary mRCC
Study reveals a 38% decreased risk of death in patients with papillary metastatic renal cell carcinoma who undergo cytoreductive nephrectomy vs those who do not.
Diagnosis & Disease Information
Metastatic Kidney Cancer Outcomes Improved With Combined Therapy
Immunotherapy with atezolizumab plus targeted therapy with bevacizumab improves progression-free survival better than sunitinib in patients with untreated metastatic renal cell carcinoma.
Low-Carb Diet Tested as Way to Slow Recurrent Prostate Cancer
In a small phase 2 study of overweight men with recurrent prostate cancer, consuming less than 20 grams of carbohydrates a day resulted in profound weight loss.
PSA Trajectory in nmCRPC Predicts Metastasis, Mortality Risk
Metastasis and death are more likely to occur among patients with relatively high PSA levels at diagnosis of nmCRPC and rising PSA levels during follow-up.
Adverse Prostate Cancer Pathology Accurately Predicted With MRI
Multiparametric MRI has high positive and negative predictive values for extracapsular extension, seminal vesicle invasion, lymph node involvement, and high-risk Gleason score.
Urologic Cancer Surgery Readmission Rate Highest for RC
In a study, nearly 20% of radical cystectomy patients were readmitted for complications within 90 days compared with 1.9% and 5.9% for radical prostatectomy and radical nephrectomy, respectively.
Early Prostate Cancer Salvage ADT Therapy Better
Among men who had PSA failure following radiation therapy for localized PCa, those with a long PSA doubling time had an increased risk of PCa mortality if they started androgen-deprivation therapy later.
Prostate Cancer Pathologic Features Worse in Blacks
Black men undergoing radical prostatectomy for prostate cancer are more likely to have indications for adjuvant radiotherapy compared with white men.
Statin Use May Improve Survival in Advanced Prostate Cancer
Statin use is associated with greater overall survival among men with metastatic castration-resistant prostate cancer and improved survival among patients with high-risk prostate cancer.
Negative Repeat Biopsy in PCa Active Surveillance a Positive Sign
In a study, a negative confirmatory prostate biopsy in prostate cancer patients on active surveillance predicts a lower risk of progressing to treatment.
- Loading...
Loading...
Next post in Genitourinary Cancers Symposium
Loading... 
Loading...